|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:CYP2B7P-EGLN2 (FusionGDB2 ID:21043) |
Fusion Gene Summary for CYP2B7P-EGLN2 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: CYP2B7P-EGLN2 | Fusion gene ID: 21043 | Hgene | Tgene | Gene symbol | CYP2B7P | EGLN2 | Gene ID | 1555 | 100529264 |
| Gene name | cytochrome P450 family 2 subfamily B member 6 | RAB4B-EGLN2 readthrough (NMD candidate) | |
| Synonyms | CPB6|CYP2B|CYP2B7|CYP2B7P|CYPIIB6|EFVM|IIB1|P450 | EGLN2|EIT-6|EIT6|HIF-PH1|HPH-1|HPH-3|PHD1|RERT-lncRNA | |
| Cytomap | 19q13.2 | 19q13.2 | |
| Type of gene | protein-coding | ncRNA | |
| Description | cytochrome P450 2B61,4-cineole 2-exo-monooxygenasecytochrome P450 IIB1cytochrome P450, family 2, subfamily B, polypeptide 6cytochrome P450, subfamily IIB (phenobarbital-inducible), polypeptide 6 | Egl nine homolog 2Estrogen-induced tag 6HIF-prolyl hydroxylase 1Hypoxia-inducible factor prolyl hydroxylase 1Prolyl hydroxylase domain-containing protein 1RAB4B-EGLN2 readthrough (non-protein coding)RAB4B-EGLN2 readthrough long non-coding RNA | |
| Modification date | 20200313 | 20200313 | |
| UniProtAcc | . | Q96KS0 | |
| Ensembl transtripts involved in fusion gene | |||